| Shares traded a day, averaged over the last 30 days. | Average return a year over the last three years. | The largest fall from a peak to the low that followed, over up to five years. | |||||||
|---|---|---|---|---|---|---|---|---|---|
| XBIState Street SPDR S&P Biotech ETF· SPDR | A | 81 | High | 0.35% | $10.4B | 8.7M | +67.1% | +30.7% | −53.2% |
| IBBQInvesco Nasdaq Biotechnology ETF· Invesco | A | 75 | High | 0.19% | $97M | 26.4K | +48.9% | +22.7% | −37.2% |
| IBBiShares Biotechnology ETF· IShares | A | 74 | High | 0.44% | $10.5B | 1.6M | +47.3% | +20.2% | −39.0% |
| BBHVanEck Biotech ETF· VanEck | B | 67 | Medium | 0.35% | $477M | 6.8K | +45.3% | +16.5% | −39.3% |
| FBTFirst Trust NYSE Arca Biotechnology Index Fund· First Trust | B | 62 | High | 0.55% | $2.9B | 58.2K | +51.7% | +23.6% | −28.6% |
| IDNAiShares Genomics Immunology and Healthcare ETF· IShares | B | 56 | Medium | 0.47% | $277M | 69K | +82.3% | +27.9% | −68.1% |
| PBEInvesco Biotechnology & Genome ETF· Invesco | C | 55 | High | 0.59% | $418M | 21K | +41.0% | +20.2% | −33.3% |
| SBIOALPS Medical Breakthroughs ETF· ALPS Funds | C | 48 | Medium | 0.50% | $226M | 37.7K | +68.8% | +34.0% | −52.5% |
| IBRNiShares Neuroscience and Healthcare ETF· IShares | C | 45 | Medium | 0.47% | $7M | 2.9K | +37.6% | +19.9% | −35.4% |
| GNMXCorgi ETF Trust I - Corgi Genomics & Precision Medicine ETF· Corgi Funds | C | 40 | Medium | 0.35% | $3M | 962 | — | — | — |
| WDNAWisdomTree BioRevolution Fund· WisdomTree | C | 40 | High | 0.45% | $5M | 2.3K | +63.7% | +18.5% | −57.7% |
| GNOMGlobal X - Genomics & Biotechnology ETF· Global X | D | 38 | Medium | 0.50% | $104M | 28.2K | +84.4% | +20.0% | −70.9% |
| HELXFranklin Genomic Advancements ETF· Franklin Templeton | D | 37 | Medium | 0.50% | $32M | 2K | +41.7% | +15.9% | −58.2% |
| ARKGARK Genomic Revolution ETF· ARK | D | 33 | High | 0.75% | $1.6B | 3.6M | +89.8% | +23.7% | −77.3% |
| CANCTema Oncology ETF· Tema | D | 31 | Medium | 0.99% | $209M | 29.8K | +56.2% | +24.2% | −28.0% |